Robin Mogg

7.2k total citations · 3 hit papers
44 papers, 2.7k citations indexed

About

Robin Mogg is a scholar working on Oncology, Infectious Diseases and Virology. According to data from OpenAlex, Robin Mogg has authored 44 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 9 papers in Infectious Diseases and 9 papers in Virology. Recurrent topics in Robin Mogg's work include HIV Research and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Statistical Methods in Clinical Trials (6 papers). Robin Mogg is often cited by papers focused on HIV Research and Treatment (9 papers), Cancer Immunotherapy and Biomarkers (8 papers) and Statistical Methods in Clinical Trials (6 papers). Robin Mogg collaborates with scholars based in United States, United Kingdom and Belgium. Robin Mogg's co-authors include Devan V. Mehrotra, Danilo R. Casimiro, Michael Robertson, Jeffrey Chodakewitz, Lawrence Corey, M. Juliana McElrath, Michael Marmor, Ann Duerr, Susan Buchbinder and Keith Gottesdiener and has published in prestigious journals such as The Lancet, Circulation and Journal of Clinical Oncology.

In The Last Decade

Robin Mogg

43 papers receiving 2.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial

2008 1.2k citations Susan Buchbinder, Devan V. Mehrotra et al. The Lancet profile →
Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation

2013 304 citations Ahmed Tawakol, Zahi A. Fayad et al. Journal of the American College of Cardiology profile →
Pembrolizumab in patients with thymic carcinoma: a single-arm, single-centre, phase 2 study

2018 277 citations Robin Mogg, Stephen V. Liu et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Robin Mogg United States	16	853	795	596	556	526	44	2.7k
Maurice R.G. O’Gorman United States	31	533 0.6×	880 1.1×	629 1.1×	473 0.9×	592 1.1×	104	2.7k
Jorge Carrillo Spain	29	405 0.5×	577 0.7×	715 1.2×	377 0.7×	379 0.7×	113	2.7k
Agostino Riva Italy	30	687 0.8×	814 1.0×	817 1.4×	512 0.9×	534 1.0×	122	3.0k
Michel Moutschen Belgium	28	399 0.5×	811 1.0×	704 1.2×	967 1.7×	708 1.3×	178	3.1k
Frank Hulstaert Belgium	30	384 0.5×	667 0.8×	381 0.6×	791 1.4×	409 0.8×	108	3.6k
Joseph A. Church United States	30	808 0.9×	1.3k 1.6×	826 1.4×	577 1.0×	538 1.0×	182	3.2k
Peng Fan China	17	647 0.8×	718 0.9×	689 1.2×	776 1.4×	278 0.5×	71	2.8k
Ombretta Turriziani Italy	27	801 0.9×	494 0.6×	1.4k 2.4×	504 0.9×	373 0.7×	135	2.9k
Chiara Agrati Italy	31	326 0.4×	1.4k 1.8×	872 1.5×	671 1.2×	397 0.8×	141	2.8k
Eugenia Quirós-Roldán Italy	32	1.1k 1.3×	712 0.9×	2.0k 3.4×	1.1k 1.9×	520 1.0×	228	4.2k

Countries citing papers authored by Robin Mogg

Since Specialization

Citations

This map shows the geographic impact of Robin Mogg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robin Mogg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robin Mogg more than expected).

Fields of papers citing papers by Robin Mogg

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robin Mogg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robin Mogg. The network helps show where Robin Mogg may publish in the future.

Co-authorship network of co-authors of Robin Mogg

This figure shows the co-authorship network connecting the top 25 collaborators of Robin Mogg. A scholar is included among the top collaborators of Robin Mogg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Robin Mogg. Robin Mogg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Waikar, Sushrut S., Robin Mogg, Amanda F. Baker, et al.. (2025). Urinary Kidney Injury Biomarker Profiles in Healthy Individuals and After Nephrotoxic and Ischemic Injury. Clinical Pharmacology & Therapeutics. 117(5). 1272–1283. 4 indexed citations

Haddad, Robert I., Tanguy Y. Seiwert, Laura Q.M. Chow, et al.. (2022). Influence of tumor mutational burden, inflammatory gene expression profile, and PD-L1 expression on response to pembrolizumab in head and neck squamous cell carcinoma. Journal for ImmunoTherapy of Cancer. 10(2). e003026–e003026. 54 indexed citations

Matthews, Randolph P., Evan Friedman, Deanne Jackson Rudd, et al.. (2021). Safety, tolerability, and pharmacokinetics of single‐ and multiple‐dose administration of islatravir (MK‐8591) in adults without HIV. Clinical and Translational Science. 14(5). 1935–1944. 29 indexed citations

Park, Jay, Robin Mogg, Gerald E. Smith, et al.. (2021). How COVID-19 has fundamentally changed clinical research in global health. The Lancet Global Health. 9(5). e711–e720. 115 indexed citations

Hendrix, Suzanne, Robin Mogg, Klaus Romero, et al.. (2021). Perspectives on Statistical Strategies for the Regulatory Biomarker Qualification Process. Biomarkers in Medicine. 15(9). 669–684. 8 indexed citations

Seiwert, Tanguy Y., Robert I. Haddad, Joshua Bauml, et al.. (2018). Abstract LB-339: Biomarkers predictive of response to pembrolizumab in head and neck cancer (HNSCC). Cancer Research. 78(13_Supplement). LB–339. 34 indexed citations

Murphy, Beth, Marija Tadin‐Strapps, Kristian K. Jensen, et al.. (2017). siRNA-mediated inhibition of SREBP cleavage-activating protein reduces dyslipidemia in spontaneously dysmetabolic rhesus monkeys. Metabolism. 71. 202–212. 9 indexed citations

Haddad, Robert I., Tanguy Y. Seiwert, Laura Q.M. Chow, et al.. (2017). Genomic determinants of response to pembrolizumab in head and neck squamous cell carcinoma (HNSCC).. Journal of Clinical Oncology. 35(15_suppl). 6009–6009. 40 indexed citations

Camacho, Anton, Rosalind M. Eggo, Nele Goeyvaerts, et al.. (2016). Real-time dynamic modelling for the design of a cluster-randomized phase 3 Ebola vaccine trial in Sierra Leone. Vaccine. 35(4). 544–551. 18 indexed citations

10.

Leaker, Brian, Robin Mogg, M. Ruddy, et al.. (2016). The nasal mucosal late allergic reaction to grass pollen involves type 2 inflammation (IL-5 and IL-13), the inflammasome (IL-1β), and complement. Mucosal Immunology. 10(2). 408–420. 54 indexed citations

11.

Tawakol, Ahmed, Zahi A. Fayad, Robin Mogg, et al.. (2013). Intensification of Statin Therapy Results in a Rapid Reduction in Atherosclerotic Inflammation. Journal of the American College of Cardiology. 62(10). 909–917. 304 indexed citations breakdown →

12.

Wang, Yue, Robin Mogg, & Jared Lunceford. (2011). Evaluating Correlation‐Based Metric for Surrogate Marker Qualification within a Causal Correlation Framework. Biometrics. 68(2). 617–627. 4 indexed citations

13.

Carayannopoulos, Leonidas N., Marcella Ruddy, Nicole Calder, et al.. (2010). Effects Of Single Doses Of Oral Corticosteroid On Biomarkers Of Nasal Allergen Challenge (NAC). A1402–A1402. 1 indexed citations

14.

Towne, Victoria, Christine Oswald, Robin Mogg, et al.. (2009). Measurement and Decomposition Kinetics of Residual Hydrogen Peroxide in the Presence of Commonly used Excipients and Preservatives. Journal of Pharmaceutical Sciences. 98(11). 3987–3996. 8 indexed citations

15.

Wallace, Mark S., Barbara J. Evans, Robin Mogg, et al.. (2009). Tolerability of Two Sequential Electroporation Treatments Using MedPulser DNA Delivery System (DDS) in Healthy Adults. Molecular Therapy. 17(5). 922–928. 44 indexed citations

16.

Quirk, Erin, Robin Mogg, Deborah D. Brown, et al.. (2008). HIV Seroconversion without Infection after Receipt of Adenovirus‐Vectored HIV Type 1 Vaccine. Clinical Infectious Diseases. 47(12). 1593–1599. 15 indexed citations

17.

Buchbinder, Susan, Devan V. Mehrotra, Ann Duerr, et al.. (2008). Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial. The Lancet. 372(9653). 1881–1893. 1215 indexed citations breakdown →

18.

Kierstead, Lisa, Sheri Dubey, Timothy W. Tobery, et al.. (2007). Enhanced Rates and Magnitude of Immune Responses Detected against an HIV Vaccine: Effect of Using an Optimized Process for Isolating PBMC. AIDS Research and Human Retroviruses. 23(1). 86–92. 60 indexed citations

19.

Tobery, Timothy W., Sheri Dubey, Daniel C. Freed, et al.. (2006). A Comparison of Standard Immunogenicity Assays for Monitoring HIV Type 1 gag-Specific T Cell Responses in Ad5 HIV Type 1 gag Vaccinated Human Subjects. AIDS Research and Human Retroviruses. 22(11). 1081–1090. 26 indexed citations

20.

Mogg, Robin & Devan V. Mehrotra. (2006). Analysis of antiretroviral immunotherapy trials with potentially non‐normal and incomplete longitudinal data. Statistics in Medicine. 26(3). 484–497. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact